Pro-Dex, Inc. (PDEX)

Pro-Dex, Inc. reported record Q3 2025 performance but experienced a stock crash. In October 2025, the company announced its fiscal 2026 first-quarter results and clarified its trading symbol. Insider sentiment has been negative due to significant open-market selling from key executives. Short interest in Pro-Dex has recently decreased, indicating improving investor sentiment. The stock price gained 0.96% on November 26, 2025, rising for five consecutive days, and is up by 13.18% over the past two weeks.

Explicit information regarding the demand seasonality for Pro-Dex, Inc.'s products and services is not directly available. Global developments, such as the COVID-19 pandemic, have driven increased demand for Pro-Dex's products, leading the company to adapt by ramping up production and focusing on supply chain resilience. Demand can be influenced by broader market trends and unforeseen global events rather than inherent seasonal patterns.

Pro-Dex, Inc. specializes in precision medical devices and components, operating within the Health Care sector. The company designs, develops, manufactures, and sells motorized surgical tools for medical device OEMs worldwide. Its major products include surgical drivers and shavers used in orthopedic, thoracic, and craniomaxillofacial markets. Pro-Dex also offers engineering expertise, regulatory advisory services, and quality compliance consulting, manufactures rotary air motors, and has a product line for dental professionals.

Pro-Dex, Inc. is headquartered in Irvine, California, with manufacturing facilities in Irvine and Tustin, California. The company's products are utilized globally in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high-tech manufacturing operations.

Pro-Dex has maintained a reputation for credibility, responsiveness, and flexibility, built over 40 years in business. The company is recognized for its expertise in product design, development, and manufacturing for OEMs. Stock volatility and insider selling activity could indirectly influence public perception among investors.

Pro-Dex, Inc. is owned by a combination of institutional shareholders and insiders. Institutional shareholders hold 23.76% of the company. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, Dimensional Fund Advisors LP, Geode Capital Management, LLC, Punch & Associates Investment Management, Inc., Northern Trust Corp, JPMorgan Chase & Co, and State Street Corp. Prominent individual and insider shareholders include Nicholas John Swenson, Ronald G. Coss, Raymond E. Cabillot, Mark Phillip Murphy, Patrick L. Johnson, Peter O. Haeg, George J. Isaac, and Jeffrey J. Ritchey.